Unless the can claim coverage under another code - coverage is lost. All those years of effort and waiting down the drain.
The will likely put the KP contract at risk. If KP can’t claim the costs they will not order the tests.
This is a company killer IMO. They have a large amount of money in the bank, but if Novartis don’t consider the rest medically necessary- game over.
Unless the can claim coverage under another code - coverage is...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PEB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 122 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 28/08/2024 (20 minute delay) ? |
| PEB (ASX) Chart |
Day chart unavailable